Medpace Central Labs Expand Singapore Facility
As part of our continuous effort to enhance our laboratory capabilities and better serve our Sponsors, Medpace is proud to announce the expansion of our…
Medpace Central Labs Expand Histology & Anatomic Pathology Services
As part of our efforts to increase laboratory services and capabilities, Medpace is excited to share that we have expanded our central laboratory histology and…
[On-Demand Webinar] Liquid Biopsy in Oncology: Opportunities and Challenges
Join featured speakers from Medpace on September 8th, as they provide an overview of the current methodologies involved in liquid biopsies and their application for…
[Webinar] Establishing Efficacy with Flow Cytometry-Based Receptor Occupancy Assays
In this on-demand webinar, experienced scientists from Medpace’s central labs discuss how flow cytometric receptor occupancy assays — when correctly implemented — are a powerful…
5 Things You Didn’t Know About Medpace’s Biorepository Services
Medpace Biorepository, a CAP accredited facility, is a key component of Medpace Central Labs and the full-service model.
Medpace Bolsters In-House Central Lab Expertise with the Addition of Three New Scientists
Medpace is pleased to announce the addition of three scientists to our Central Laboratory leadership team.
The First Controlled Clinical Trial For A CRISPR Enhanced Bacteriophage Therapy
In a recent article published in Clinical Leader, Ed Miseta, Chief Editor highlights Medpace's partnership with Locus Biosciences and their development of crPhage™, a bacteriophage…
China Central Lab Expansion
As part of our efforts to expand laboratory services and capabilities, specifically in Asia, Medpace has relocated our central laboratory facilities from Beijing to Shanghai.…
Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers
We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…
Minimizing Disruption to Clinical Trials During COVID-19
Medpace is committed to keeping Sponsors on PACE to maintain regular activity during this irregular time.